Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies.

about

Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies.

Item

http://www.wikidata.org/entity/Q45942661

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Optimized purification strateg ...... fic monoclonal autoantibodies.

@en

Optimized purification strateg ...... fic monoclonal autoantibodies.

@nl

type

Item

label

Optimized purification strateg ...... fic monoclonal autoantibodies.

@en

Optimized purification strateg ...... fic monoclonal autoantibodies.

@nl

prefLabel

Optimized purification strateg ...... fic monoclonal autoantibodies.

@en

Optimized purification strateg ...... fic monoclonal autoantibodies.

@nl

P1476

Optimized purification strateg ...... fic monoclonal autoantibodies.

@en

P2093

Anne-Marie Madec

http://www.w3.org/2001/XMLSchema#string

Henriette Macmillan

http://www.w3.org/2001/XMLSchema#string

Wei Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.

Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.

Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.

Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes.

Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase

The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated.

Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.

Autoantibodies in type 1 diabetes.

COOH-Terminal Clustering of Autoantibody and T-Cell Determinants on the Structure of GAD65 Provide Insights Into the Molecular Basis of Autoreactivity

P304

135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.6467.1

http://www.w3.org/2001/XMLSchema#string

10.12688/F1000RESEARCH.6467.2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth D Mellins

P577

2015-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29167731

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

5680538

http://www.w3.org/2001/XMLSchema#string